Anticoagulant therapy during pregnancy is proble
matic. Patients are
frequently treated with long-ter
m low-
molecular weight heparin despite a lack o
f evidence
for its e
ffectiveness, and in the absence o
f validated dosing reco
mmendations. The objectives o
f this investigation were to characterize the sa
fety and phar
macokinetic behavior o
f a low-
molecular weight heparin (reviparin) ad
ministered throughout pregnancy. Forty-two patients
followed in a tertiary-care rheu
matology clinic who received prophylactic doses o
f reviparin (4900 anti-Xa units subcutaneously once daily) were enrolled in this investigation. Anti-Xa heparin levels, weights, and gestational ages o
f the patients were obtained on up to
four occasions distributed throughout their pregnancy. The achieved anti-Xa heparin levels were highly correlated with the patient's weight, irrespective o
f the gestational age. No toxicity other than injection site he
mato
mas was observed. The achieved intensity o
f anticoagulation with reviparin varies during pregnancy in direct proportion to the patient's weight. This variability
may
mandate dose adjust
ment in response to changes in a patient's weight during pregnancy, particularly i
f low-
molecular weight heparin is ad
ministered at therapeutic doses.
font>
<font face=""arial"" size=""-1"" color=""black""> Publisher: font> | <font face=""arial"" size=""-1"" color=""black""> Elsevier Science font> |
<font face=""arial"" size=""-1"" color=""black""> Language of Publication: font> | <font face=""arial"" size=""-1"" color=""black""> English font> |
<font face=""arial"" size=""-1"" color=""black""> Item Identifier: font> | <font face=""arial"" size=""-1"" color=""black""> S0049-3848(99)00228-5 font> |
<font face=""arial"" size=""-1"" color=""black""> Publication Type: font> | <font face=""arial"" size=""-1"" color=""black""> Article font> |
<font face=""arial"" size=""-1"" color=""black""> ISSN: font> | <font face=""arial"" size=""-1"" color=""black""> 0049-3848 font> |
<font face=""arial"" size=""-1"" color=""black""> Cited by: font> | <font face=""arial"" size=""-1"" color=""black""> - Eldor, Amiram,""The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy""European Journal of Obstetrics and Gynecology and Reproductive Biology2002pp. 3-13
f=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=03012115&issue=v104i0001&article=3_tuolhfmovtip"">Bibliographic Pagef=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=03012115&issue=v104i0001&article=3_tuolhfmovtip&form=pdf&file=file.pdf"">Full Text - Empson, Marianne; Lassere, Marissa; Craig, Jonathan C.; Scott, James R.,""Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trialsf=""#footnote_2"">2""Obstetrics and Gynecology2002pp. 135-144
f=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=00297844&issue=v99i0001&article=135_rplwaaasrott"">Bibliographic Pagef=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=00297844&issue=v99i0001&article=135_rplwaaasrott&form=pdf&file=file.pdf"">Full Text - Jacobsen, Anne Flem; Qvigstad, Erik; Sandset, Per Morten,""Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy""BJOG: An International Journal of Obstetrics and Gynaecology2003pp. 139-144
f=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=14700328&issue=v110i0002&article=139_lmwhfttovtip"">Bibliographic Pagef=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=14700328&issue=v110i0002&article=139_lmwhfttovtip&form=pdf&file=file.pdf"">Full Text - Massicotte, Patricia; Julian, Jim A.; Marzinotto, Velma; Gent, Michael; Shields, Karen; Chan, Anthony K.; Szechtman, Barbara; Kohne, Steven; Shepherd, Steven; Bacher, Peter; Andrew, Maureen,""Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients""Thrombosis Research2003pp. 93-99
f=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=00493848&issue=v109i2-3&article=93_dappopmwhipp"">Bibliographic Pagef=""http://202.120.13.78/cgi-bin/sciserv.pl?collection=journals&journal=00493848&issue=v109i2-3&article=93_dappopmwhipp&form=pdf&file=file.pdf"">Full Text font> |
| <font face=""arial"" size=""-1"" color=""black""> Footnotes: me=""footnote_1"">The results of this paper were presented at the International Society of Thrombosis and Hemostasis Meeting in Washington D.C. in August of 1999.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号
地址:北京市海淀区学院路29号 邮编:100083
电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700
| |
|